“…This study was approved by the institutional review board of the New York Eye and Ear Infirmary. After informed consent was obtained, 18 glaucoma patients (10 men, 8 women) with known apraclonidine allergy were enrolled. Ten patients had a history of apraclonidine allergy and agreed to be rechallenged in order to document the allergy.…”